Enochian BioSciences
2001
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
3
FINANCING ROUNDS
Description
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.
Website
Formerly Known As
DanDrit Biotech USA
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Enochian Biopharma
Primary Office
- 375 Park Avenue
- Suite 2607
- New York, NY 10152
- United States
Enochian BioSciences Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Enochian BioSciences‘s full profile, request access.
Request full access to PitchBookEnochian BioSciences Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Northwest Biotherapeutics | Private Equity-Backed | Bethesda, MD | 00 | 00000 | 000000000 | 00000 |
| 0000000000 | Corporate Backed or Acquired | Baton Rouge, LA | 000000000000 | |||
| 0000000 0000000000 | Formerly VC-backed | Watertown, MA | 00 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000 00000000000000 | Venture Capital-Backed | Philadelphia, PA | 000.00 | 0000000000 0 | 000.00 |